JPRN-UMIN000023999
Completed
未知
The randomized controlled trial on the efficacy of mobile-app delivered cognitive behavioral therapy for insomnia - Mobile-app delivered cognitive behavioral therapy for insomnia
europsychiatric Research Institute0 sites40 target enrollmentSeptember 12, 2016
ConditionsInsomnia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Insomnia
- Sponsor
- europsychiatric Research Institute
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Unable to use smartphone circadian rhythm disorder sleep apnea syndrome Restless legs syndrome hypersomnia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The randomized controlled trial on the efficacy of cognitive behavior therapy for insomniaJPRN-UMIN000014297Department of Psychophysiology, National Institute of Mental Health, National Center of Neurology & Psychiatry60
Completed
Phase 3
The randomized controlled trial of the efficacy of goshajinkigan, mecobalamin and lafutidine in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010969Department of breast and endocrine surgery, Meiwa Hospital50
Completed
Phase 3
The randomized controlled trial of the efficacy of goshajinkigan and lafutidine after mecobalamin administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010988Department of breast and endocrine surgery, Meiwa Hospital35
Completed
Phase 3
The randomized controlled trial of the efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000011007Department of breast and endocrine surgery, Meiwa Hospital35
Not yet recruiting
Phase 1
A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)ITMCTR2000003033Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,